Dibenzepin Hydrochloride

CHEMBL2104287 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

331.8 g/mol

LogP

—

Phase

4

A hydrochloride salt form of dibenzepin with the same tricyclic antidepressant effects as the parent compound. It is used to treat depressive disorders.

Moleküler Ağırlık

331,8000 g/mol

TPSA

26,80 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21.Cl

InChI

InChI=1S/C18H21N3O.ClH/c1-19(2)12-13-21-17-11-7-6-10-16(17)20(3)15-9-5-4-8-14(15)18(21)22;/h4-11H,12-13H2,1-3H3;1H

Molecular Formula

C18H22ClN3O

HBD / HBA

1 / 3

Döndürülebilir Bağlar

3

Ağır Atomlar

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A hydrochloride salt form of dibenzepin with the same tricyclic antidepressant effects as the parent compound. It is used to treat depressive disorders.

Yes, Dibenzepin Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2104287. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 443945. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Dibenzepin Hydrochloride PillFYI'da

Yapı

Hızlı Veriler

Formül: C18H22ClN3O

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.